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PAPILLOMAS AND CARCINOMAS
OF THE CHOROID PLEXUS
Histological and immunohistochemical studies 
and comparison with normal fetal choroid plexus
Ana Silvia Carvalho de Menezes Barreto1, José Vassallo1, Luciano de Souza Queiroz1
ABSTRACT - Background: Choroid plexus tumors are rare. Results on immunohistochemical features are
scanty and controversial even regarding normal plexus. Method: Thirteen cases of choroid plexus tumors
and five samples of normal fetal choroid plexus were submitted to immunohistochemical study using a
panel of epithelial, neuronal and stromal markers. Results/Conclusions: Relevant histological findings were
presence of clear cells in 3/5 papillomas (PP) and 7/8 carcinomas (CA) and all 5 fetal plexuses; rhabdoid cells,
desmoplasia and vascular proliferation were found respectively in 3, 4 and 5 cases out of 6 poorly differ-
entiated CA and were absent in PP and well differentiated CA. Pancytokeratin AE1/AE3 was strongly pos-
itive in all 13 cases, even in the undifferentiated component of poorly differentiated CA, where reactivity
was focal in 3 and diffuse in 3 cases. Low molecular weight cytokeratin (35βH11) was not expressed in any
of the 8 CA, but was present in all 5 PP. In 4 of 6 poorly differentiated CA there was reactivity for smooth
muscle actin (1A4) in 10 to 30% of the cells. This was true also for one case lacking rhabdoid cells. Laminin
was undetectable in all 6 cases of poorly differentiated CA but was present in 4 PP and 2 well differenti-
ated CA. All 5 fetal plexuses expressed GFAP. 
KEY WORDS: choroid plexus tumors, normal fetal choroid plexus, immunohistochemistry, central nervous
system.
Papilomas e carcinomas do plexo coróide: estudo histológico e imuno-histoquímico e compara-
ção com plexo coróide fetal normal
RESUMO - Contexto: Os tumores do plexo coróide são raros. Os resultados de dados imuno-histoquímicos
são escassos e controversos, o mesmo valendo para o plexo coróide normal. Método: Treze casos de tumores
do plexo coróide e cinco exemplares de plexo coróide fetal normal foram submetidos a estudo imuno-his-
toquímico, utilizando-se marcadores para antígenos epiteliais, neurais e estromais. Resultados/Conclusão:
Os achados histológicos mais relevantes foram células claras em 3/5 papilomas (PP) e 7/8 carcinomas (CA)
e em todos os 5 plexos fetais; células rabdóides, desmoplasia e proliferação vascular foram encontradas,
respectivamente, em 3, 4 e 5 casos de 6 CA pouco diferenciados, mas não nos PP e CA bem diferenciados.
A pancitoqueratina AE1/AE3 foi fortemente positiva em todos os 13 casos, mesmo no componente indiferen-
ciado do CA pouco diferenciado, em que a reatividade foi focal em 3 casos e difusa em outros 3. A citoque-
ratina de baixo peso molecular (35βH11) não foi expressa em nenhum dos 8 CA, mas estava presente em
todos os 5 PP. Em 4/6 CA pouco diferenciados houve reatividade para actina de músculo liso (1A4) em 10-
30% das células. Este achado ocorreu também em um caso sem células rabdóides. Laminina não foi detec-
tada em nenhum dos 6 CA pouco diferenciados, mas estava presente em 4 PP e em 2 CA bem diferencia-
dos. Todos os 5 plexos fetais expressaram GFAP.
PALAVRAS-CHAVE: tumores do plexo coróide, plexo coróide fetal normal, imuno-histoquímica, sistema ner-
voso central.
Choroid plexus tumors are infrequent (0.4-1%
of central nervous system (CNS) tumors)1-5 and
their immunohistochemical pattern is still contro-
versial, in part due to the paucity of cases available
for study, particularly among the malignant vari-
ants. Choroid plexus cells are truly epithelial in
nature as demonstrated by ultrastructural and im-
munohistochemical studies6-15. Most studies report
Arq Neuropsiquiatr 2004;62(3-A) 601
reactivity to cytokeratins (CK), especially of low mo-
lecular weight, vimentin, epithelial membrane anti-
gen (EMA), transthyretin (TTR), S100 protein, glial
fibrillary acidic protein (GFAP) and neuron specific
enolase (NSE), but the frequency of reaction varies
greatly6,9-11,13,14,16-21. In contrast, normal choroid
plexus, fetal or adult, has been described as cons-
tantly negative to GFAP, with rare exceptions7-15.
Poorly differentiated choroid plexus CA, especial-
ly in pediatric patients with posterior fossa neo-
plasms, must be distinguished from other anaplas-
tic tumors with solid diffuse pattern and undiffe-
rentiated cells, such as the rare and controversial aty-
pical teratoid / rhabdoid tumor (AT/RT)22-25. In these
situations an immunohistochemical panel may be
helpful.
The variation of results in the literature concern-
ing the immunohistochemical patterns in choroid
plexus tumors and in the normal choroid plexus
prompted us to study their immunoreactivity using
a panel of epithelial, neuronal and stromal mark-
ers. It was also intended to compare these findings
with the normal fetal choroid plexus to evaluate
whether neoplastic cells may show immunohisto-
chemical features of fetal cells.
METHOD
Cases of choroid plexus tumors occurring in patients
up to the age of 25 years between 1966 and 1999 were
selected from the files of the Department of Anatomic
Pathology, State University of Campinas, São Paulo,
Brazil. This study was approved by the Ethics Committee
of the Faculty of Medical Sciences of our institution. Only
those cases in which paraffin embedded tissue was avail-
able for immunohistochemical study and the amount of
tissue was large enough (at least 1.5 cm in largest diam-
eter) were included. Age and sex of patients and topog-
raphy of the tumors were recorded. Archival slides sta-
ined with H&E were reviewed for diagnosis. Cases we-
re classified according to the WHO nomenclature26 as pa-
pilloma (PP) and carcinoma (CA). We further divided the
carcinomas into well [WCA] or poorly differentiated
[PCA], similarly to what was done by others21,27. Five ca-
ses of normal fetal choroid plexus (NFCP) (between 16
and 40 gestational weeks) were also studied to compare
their immunohistochemical pattern with those of tumors.
New sections were cut for immunohistochemical stu-
dies, placed on silanized slides, dewaxed and hydrated.
Antigen retrieval was achieved by immersing slides in
citrate buffer, pH 6.0, 10 mM, for 25 minutes in steam-
er (95o C). Sections were incubated with the primary anti-
bodies at 4o C overnight (Table 1). Revelation of the reac-
tion was made using the streptavidin-biotin-peroxidase
complex (Dakopatts, Carpenteria, USA), stained with
3,3-diaminobenzidine, and counterstained with hema-
toxylin.





Epithelial membrane antigen (EMA) 1:80





Neuron specific enolase, monoclonal (NSE) 1:100
Glial fibrillary acid protein (GFAP) 1:100
Transthyretin protein (TTR) 1:100
Desmin, D33 1:20
Smooth muscle actin, 1A4 1:25
Laminin 1:1000
P53 protein, DO7 1:100
Source of antibodies: Dakopatts, Carpenteria, USA.
Table 2. Immunodetection of proteins in choroid plexus tumors
and fetal normal choroid plexus.
Markers PP WCA PCA Fetal choroid
N=5 N=2 N=6 plexus n=5
AE1/AE3 5 2 6 4
35βH11 5 0 0 0
34βE12 0 0 0 0
EMA 2 0 4 2
CEA 1 0 2 0
Vimentin 5 1 6 5
S100 4 2 6 5
NF 0 0 0 1
SNF 5 2 1 4
NSE 5 2 6 4
GFAP 5 0 5 5
TTR 5 2 5 5
Desmin 4 0 0 3
1A4 2 0 4 2
Laminin 4 2 0 5
P53 0 0 0 0
PP, choroid plexus papilloma; WCA, well differentiated carcinoma; PCA,
poorly differentiated carcinoma. Markers: see Table 1.
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Cases were considered positive when at least 10%
of the cells showed the characteristic brown staining,
either in the nuclei, cytoplasm or membrane, according
to each antibody pattern. The frequency of antigen im-
munodetection was studied comparatively in each tumor
group and in normal fetal choroid plexus. 
RESULTS
Between 1966 and 1999, 184 cases of CNS tumor
were diagnosed in patients younger than 25 years.
Thirteen (7%) corresponded to choroid plexus tu-
mors: 5 PP and 8 CA (2 WCA and 6 PCA). Among
the PP 3 patients were females and 2 males; age
Fig 1. All sections stained with hematoxylin and eosin (HE). A and B) Well differentiated choroid
plexus carcinoma: (A) cells arranged in single layer around capillaries forming papillary structures.
(Bar 100 µm); (B) the lower half of the picture shows part of a papilla; in the upper half, cells are
loose and an atypical mitotic figure is seen. (Bar 25 µm). C and D) Poorly differentiated choroid
plexus carcinoma: (C) neoplastic cells forming solid sheets, with poorly defined cell limits; no pap-
illary arrangement can be seen; in the upper left hand corner, area of coagulative necrosis. (Bar
50 µm); (D) detail, showing variation in nuclear size, nucleoli, and an atypical mitotic figure at
center. (Bar 25 µm).
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ranged between 1 month and 25 years, with medi-
an age of 1y 6mo. In 2 cases tumors were intraven-
tricular without specification, one was in the pos-
terior fossa / IV ventricle, another in the left later-
al ventricle and in one case no information was ava-
ilable. Among the CA 6 patients were females and
2 males; age ranged between 5 months and 3
years, with median of 11 months. In one case tu-
mor was intraventricular without specification, 5
were in the posterior fossa / IV ventricle and in 2
no information was available.
The cases of choroid plexus papillomas recalled
the normal architecture of the choroid plexus: cu-
boidal or columnar epithelial cells formed a mono-
layer on papillary vascular connective tissue stro-
ma. The nuclei were ovoid, with regular, well distri-
buted chromatin and the luminal surface of the
neoplastic epithelium was smooth and straight, as
opposed to the hobnail appearance of normal cho-
roid epithelium. The PP tended to have higher cel-
lularity than normal choroid plexus, although no
quantitation was attempted. Choroid plexus carci-
Fig 2. All sections stained with HE. Poorly differentiated choroid plexus carcinoma. (A) Area of
vascular endothelial proliferation and thickening of a connective tissue septum. (Bar 100 µm). (B)
Clear cell pattern. (Bar 50 µm). (C) Rhabdoid cell at center. (Bar 25 µm).
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nomas were characterized by unequivocal malignant
features, such as cytological atypia, necrosis, mitot-
ic activity, brain invasion and/or loss of papillary
architecture. Carcinomas were subclassified into
well differentiated (WCA) and poorly differentiat-
ed (PCA) based on the predominance of papillary
vs solid areas. There were 2 cases of WCA, with at
least 50% of papillary areas and 6 PCA (Fig 1). Of
these, only one showed a single focus of papillary
structures. The other 5 consisted of solid tissue only.
Besides these characteristic findings, some note-
worthy observations were found in our cases. Vas-
cular endothelial proliferation was found in 3 of
6 PCA (Fig 2A). In the same 3 cases, stromal prolif-
eration formed thick irregular septa (Fig 2A). Pe-
rivascular pseudorosettes were present in the 2 cas-
es of WCA and in 5 out of 6 cases of PCA. Clear cells
were a common finding (3/5 PP, 2/2 WCA and 5/6
PCA), mostly in focal areas (Fig 2B). In one case of
PCA larger areas of clear cells were seen. These cells
were a major finding in all examples of fetal cho-
roid plexus examined. In every case, PAS reaction
was negative in clear cells. Rhabdoid cells were
found in 3 out of 6 PCA (Fig 2C). They were obser-
ved mostly in perivascular distribution and were
characterized by clear vesicular nuclei, with single
prominent nucleolus and abundant acidophilic
cytoplasm devoid of the classical hyaline body usu-
al in rhabdoid cells. These cells showed immunore-
activity for smooth muscle actin 1A4.
Fig 3. Positivity respectively for: (A) AE1/AE3, (B) GFAP, (C) 1A4 (all in poorly differentiated carci-
nomas) and (D) laminin (in well differentiated carcinoma). (Immunoperoxydase, bars 25 µm).
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Immunohistochemical findings are summarized
in Table 2 and shown in Figure 3, for AE1/AE3, GFAP,
1A4 and laminin.
DISCUSSION
Case selection was limited to ages from birth
to 25 years because of the high incidence of choroid
plexus tumors in the pediatric population with
significant decrement after the second decade. 
Some noteworthy points regarding frequency,
histopathological features and immunohistochem-
istry of choroid plexus tumors in childhood arose
from our study. Choroid plexus tumors account for
1.5 to 3.9% of CNS tumors in children, PP being at
least four times more common than CA1,2. There is
slight male predominance and the lateral ventricles
are the most common site at this age. In the pres-
ent series, the frequency of choroid plexus tumors
was 7% (5 PP and 8 CA = 13 cases among 184 CNS
tumors). The predominance of carcinomas as com-
pared to papillomas does not reflect the incidence
of the general population, since difficult cases from
other institutions are often referred to our hospi-
tal. There was female predominance (9 F, 4 M). As
regards tumor location, 3 cases were intraventric-
ular without specification, 6 were situated in the pos-
terior fossa / IV ventricle, one in the left lateral ven-
tricle and in 3 no information was available. 
While histological criteria for well differentiat-
ed choroid plexus tumors are clearly established26,28
the diagnosis of poorly differentiated variants is
not so well defined. 
In our series, vascular endothelial proliferation
and stromal desmoplasia forming thick irregular
septa were present in 3/6 cases of PCA. This fea-
ture is frequently seen in astrocytic neoplasms, in
which it is related to the degree of anaplasia and
used as a criterion for histological grading. Endo-
thelial proliferation is often found in high grade
astrocytomas, in which the stimulus for prolifera-
tion is attributed to the production of angioproli-
ferating factors by the neoplastic astrocytes them-
selves29. It is therefore possible that the findings
of vascular proliferation and stromal desmoplasia
in PCAs might hint at some sort of astrocytic dif-
ferentiation of the choroid neoplastic cells. It
should be recalled that the choroid plexus cell
derives from a neuroepithelial common precursor
cell, the so called oligopotential glio-ependymal
precursor10,11,17.
Perivascular pseudorosettes were seen only in
WCA and PCA (2/2 WCA and 5/6 PCA) and may cau-
se diagnostic difficulties with anaplastic ependymo-
mas. While the perivascular pseudorosettes might
be an indication of ependymal differentiation of
the choroid neoplastic cells, it must also be kept
in mind that ischemic necrosis of tumor cells at some
distance from blood vessels might create a similar
pattern. 
Clear cells were common in all choroid plexus
tumors, benign and malignant. As they are also very
frequent in the fetal choroid plexus, they may sug-
gest similarities between the neoplastic cells and
immature related tissue.
Concerning the immunohistochemical profile,
pancytokeratin AE1/AE3 was strongly positive in
all tumor cases, even in the undifferentiated com-
ponent of PCA, where reactivity was focal in 3
and diffuse in 3 cases. In contrast to the litera-
ture8,9,14,18,19,21, low molecular weight cytokeratin
(35βH11) was not expressed in any of 8 CA, but was
present in all 5 PP. In 4/6 PCA, including one with-
out rhabdoid-like features, there was reactivity
for smooth muscle actin 1A4, which could be detec-
ted in 10 to 30% of the cells. Also, differently from
some reports19, laminin was not a helpful tool in
the diagnosis of PCA, as it was not detected in any
of the 6 cases. All 5 NFCP expressed GFAP, in con-
trast with previous reports8-11,13. Absence of expres-
sion of 35βH11 among all 5 cases of NFCP was sim-
ilar to what was obtained in CA. On the other
hand, all PP showed positivity. 
The main histological and immunohistochem-
ical criteria for classifying the undifferentiated tu-
mors as choroid plexus CA were respectively the
diffuse, solid growth pattern without a fibrillary
background, the presence of a scant rim of cyto-
plasm in the small, round cells and strong reactiv-
ity for pancytokeratin AE1/AE3 in the undifferentia-
ted component. Some PCA showed immunoreac-
tion to 1A4, which could cause difficulties in diffe-
rential diagnosis with the rare and controversial
AT/RT, also present in the posterior fossa of young
children (usually before one year of age)22,23. Ho-
wever, in PCA the pattern of positivity was distinct
from that found in AT/RT in that it did not corre-
late exclusively with the rhabdoid-like cells but
also with scattered undifferentiated epithelial and
perivascular tapering cells. There was 1A4 positiv-
ity even in a case lacking the rhabdoid-like com-
ponent. 
Differential diagnosis between choroid plexus
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PCA and AT/RT may be difficult. The main criteria
favoring PCA were homogeneity of the histolog-
ical picture, without heterologous elements often
found in AT/RT, such as mesenchimal areas, epithe-
lial differentiation into both squamous and glandu-
lar tissue. AT/RT are characterized by rhabdoid
cells with globular intracytoplasmic bodies in 100%
of cases, and a neuroectodermal (PNET) compo-
nent evident in two thirds (predominant in 15-
65%). In our cases, the undifferentiated compo-
nent, although diffuse, was epithelial-like with scant
cytoplasm. However, recent genetic studies have
shown important similarities between choroid plexus
carcinomas and AT/RT, both of which show inacti-
vating mutations of the hSNF5/INI-1 gene in chro-
mossome 22q11.2, considered an important step in
the molecular pathogenesis of AT/RT. This points to
a close relationship between these two entities30.
Furness et al19 detected laminin in subepithelial
location and fragmented pattern in all choroid ple-
xus CA; in contrast our PCAs did not show laminin,
possibly due to the very undifferentiated state of
the neoplastic cells without any reminiscence of
papillary structures. On the other hand, PP (4/5)
and all 5 NFCP showed strong, linear and continu-
ous membrane reactivity for laminin. In both WCA
laminin was found in a fragmented pattern. 
The positivity to vimentin and S100 protein in
almost all cases of PP, CA and NFCP is in agreement
with other reports9,10,14,21 that both are associated
with tissues derived from the neuroectodermal plate.
Unlike some reports11,14,19-21, in our cases there
was no correlation between the degree of tumor
anaplasia and immunodetection of CEA, TTR and
EMA. TTR was positive in all tumors and in NFCP,
except one PCA. EMA showed positivity in 2/5 PP,
4/6 PCA and 2/5 FCP, and CEA in 1/5 PP and 2/6 PCA.
As most reports in the literature10,11,13,14,16-19,21,31,
GFAP was strongly and widely expressed among all
PP and 5/6 PCA, implying, as Rubinstein and Bru-
cher16 proposed that during neoplastic develop-
ment choroid plexus epithelial cells express a fea-
ture which is the prerogative of glial and ependy-
mal related cells. However in Rubinstein’s and oth-
er authors’ studies8-11,13 of normal choroid plexus,
there was no glial marker immunodetection, with
rare exceptions14. Two explanations have been pro-
posed: first, antigen retrieving techniques have
been considerably improved compared to a decade
ago when most of the reports were published; and
second, most of the normal plexus studied were
adult samples. In children choroid plexus cells may
have greater propensity to divergent differentia-
tion17. In summary, neoplastic choroid cells, either
benign or malignant, and immature normal fetal
choroid cells retain the genetic information of their
parental neuroepithelial precursors which code for
a glial phenotype in their progeny16. 
The p53 tumor suppressor protein was negative
in all cases examined suggesting that, in contrast
to astrocytomas, p53 mutation seems not to be im-
portant in the pathogenesis or progression of
choroid plexus tumors. The actual role of the im-
munodetection of the p53 protein is still controver-
sial, as other authors show high positivity of this
protein mainly in choroid plexus carcinomas, al-
though in variable intensities32,33. However, in a
study including 10 choroid plexus tumors, Ohgaki
et al34 did not find mutations in exons 5-8 of the
p53 gene, what is in accordance with our finding.
CONCLUSIONS
Pancytokeratin (AE1/AE3) was expressed in all
choroid plexus PP, CA and 80% of NFCP.
Low molecular weight cytokeratin (35βH11)
was expressed in all PP but not in CA or NFCP.
Expression of epithelial markers (AE1/AE3 and
EMA) is important to define the epithelial nature
of the tumor, particularly in undifferentiated areas. 
An immunohistochemical panel of 16 antibod-
ies is useful to help distinguish PCA from other
anaplastic tumors, such as AT/RT. 
Fetal choroid plexus demonstrates multipotential-
ity through coexpression of various markers: VIM, TTR,
S-100, GFAP (100%), SNF, NSE, AE1/AE3 (80%), desmin
(60%), EMA, 1A4 (40%) and NF (20%). 
Laminin was not detected in PCA, but was use-
ful for highlighting the basal lamina in PP and WCA. 
Mutations of p53 gene do not appear impor-
tant in pathogenesis and progression of choroid
plexus tumors. 
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